Table 1 Summery of baseline findings by diagnosis category
From: Cerebrospinal fluid pleocytosis level as a diagnostic predictor? A cross-sectional study
Diagnosis category | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CNS infection (n = 106) | Infection outside CNS (n = 20) | Non-infectious neurological diseases (n = 79) | Malignancy, all foci (n = 23) | Other (n = 34) | Total (n = 262) | |||||||
Sexa | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||||||
Male | 49 (46.2) | 11 (55.0) | 43 (54.4) | 14 (60.9) | 16 (47.1) | 133 (50.8) | ||||||
Female | 57 (53.8) | 9 (45.0) | 36 (45.6) | 9 (39.1) | 18 (52.9) | 129 (49.2) | ||||||
Ageb | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||||||
< 36 yrs | 26 (24.5) | 5 (25.0) | 24 (30.6) | 2 (8.7) | 7 (20.6) | 64 (24.4) | ||||||
36-51 yrs | 31 (29.3) | 27 (34.2) | 6 (26.1)* | 7 (20.6) | 71 (27.1) | |||||||
52-64 yrs | 20 (18.9) | 4 (20.0) | 14 (17.7) | 9 (39.1) | 13 (38.2) | 60 (22.9) | ||||||
≥ 65 yrs | 29 (27.4) | 11 (55.0) | 14 (17.7) | 6 (26.1) | 7 (20.6) | 67 (25.6) | ||||||
Mean | 50.4 | 58.5 | 46.1* | 59.1 | 52.0 | 50.7 | ||||||
Range | 15–88 | 17–91 | 20–89 | 28–81 | 17–95 | 15–95 | ||||||
Charlson scorea | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||||||
0 | 66 (62.3) | 9 (45.0) | 52 (65.8) | 1 (4.4) | 19 (55.9) | 147 (56.1) | ||||||
1 | 25 (23.6) | 3 (15.0) | 18 (22.8) | 1 (4.4) | 9 (26.5) | 56 (21.4) | ||||||
2 | 7 (6.6) | 5 (25.0) | 5 (6.3) | 14 (60.9) | 6 (17.7) | 37 (14.1) | ||||||
3 | 2 (1.9) | 2 (10.0) | 2 (2.5) | 3 (13.0) | 9 (3.4) | |||||||
≥4 | 6 (5.7) | 1 (5.0) | 2 (2.5) | 4 (17.4) | 13 (5.0) | |||||||
Mean | 0.7 | 1.2 | 0.6 | 2.7** | 0.6 | 0.9 | ||||||
Range | 0–6 | 0–4 | 0–7 | 0–11 | 0–2 | 0–11 | ||||||